Minds and Mentors Program for Opioid Use Disorder
(MiMP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test the effectiveness of a new program, Minds and Mentors, for individuals with opioid use disorder who are already taking medications like methadone or naltrexone. Participants will be randomly assigned to either the Minds and Mentors program, which combines mindfulness and peer mentoring, or a traditional Twelve Step program. The research will explore whether Minds and Mentors helps participants adhere to their medication, reduces cravings, and lowers stress and anxiety. Individuals diagnosed with opioid use disorder, currently on medication, and not actively detoxing might be suitable for this trial. Participants must be willing to attend group sessions and have access to a smartphone or computer.
As an unphased trial, this study offers a unique opportunity to explore innovative treatment options and contribute to groundbreaking research.
Do I have to stop taking my current medications for the trial?
No, you don't have to stop taking your current medications. In fact, you need to be stable on your medications for mood or anxiety disorders for at least two weeks before starting the trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
A previous study on the Minds and Mentors Program (MiMP), which combines mindfulness-based relapse prevention and peer mentoring, showed promise for individuals with substance use disorders. Research has shown that mindfulness-based methods, like those in MiMP, are generally easy for participants to manage, with many finding them acceptable and practical. Importantly, these studies did not report any major safety concerns, suggesting the treatment is relatively safe.
For those considering such programs, it is reassuring to know that these mindfulness techniques aim to help without adding significant risk. Participants often report reduced cravings and stress, which can benefit those dealing with opioid use disorder. Always consult healthcare providers for personalized advice.12345Why are researchers excited about this trial?
Researchers are excited about the Minds and Mentors Program for opioid use disorder because it combines mindfulness-based relapse prevention with peer mentoring, offering a fresh approach to treatment. Unlike traditional options like methadone or buprenorphine, which focus on managing withdrawal symptoms, this program emphasizes mental resilience and community support. The unique combination of group therapy led by both licensed counselors and peer mentors aims to provide a supportive network and practical skills to reduce the risk of relapse, offering a more holistic approach to recovery.
What evidence suggests that this trial's treatments could be effective for opioid use disorder?
Research has shown that mindfulness-based relapse prevention (MBRP), which participants in this trial may receive as part of the Minds and Mentors Program, can help treat opioid addiction. Studies have found that MBRP reduces cravings, relapse rates, and feelings of anxiety and depression. The program combines mindfulness techniques with peer support, aiding adherence to medication for opioid addiction. Previous studies indicate that these combined methods yield better results than traditional treatments alone. This evidence suggests that the Minds and Mentors Program could effectively manage opioid addiction. Meanwhile, another group in this trial will participate in a 12 Step Treatment Program, serving as an active comparator.13467
Are You a Good Fit for This Trial?
This trial is for adults over 19 with opioid use disorder who are currently on medication-assisted treatment (like methadone or buprenorphine). They must be stable on their medication, able to attend 12 therapy sessions and follow-ups for 9 months, have internet access, and not be in immediate need of intensive care like detox. Pregnant women, those with unstable medical conditions or active psychosis, suicidal thoughts, or significant cognitive impairment cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Minds and Mentors Program or Twelve Step Facilitation for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Minds and Mentors
- Twelve Step Intervention Group
Trial Overview
The study tests the Minds and Mentors Program against a Twelve Step Facilitation program for people using medications to treat opioid addiction. Participants will randomly receive one of these treatments in groups of five. The goal is to see if the program helps stick to treatment better, reduces relapse and cravings, lowers anxiety/stress/depression levels, and affects cortisol related to drug cues.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Treatment will utilize a group format. The twelve-week mindfulness based relapsed prevention group therapy intervention is co-led by a licensed counselor and a peer mentor for eight weeks, followed by group sessions led by peer mentors for an additional four weeks.
Participants in the attentional control group will attend 12 weeks of a enhanced 12 step treatment program.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama, Tuscaloosa
Lead Sponsor
University of Alabama at Birmingham
Collaborator
Tuscaloosa Veterans Affairs Medical Center
Collaborator
Pathway Healthcare, LLC
Collaborator
Citations
NCT04233671 | Minds and Mentors Program (MiMP)- R61
The goal of the proposed study is to determine the effectiveness of a mindfulness-based intervention that also utilizes peer mentors in addition to professional ...
The methods and baseline characteristics of a multi-site ... - PMC
This paper describes the methods and baseline characteristics of a multi-site randomized controlled trial evaluating the effectiveness of a combination of MBRP ...
Minds and Mentors Program- R33 (MiMP) - ClinicalTrials.Veeva
The purpose of this study is as follows: Test the effectiveness of the Minds and Mentors Program in a group treatment trial in which individuals ...
4.
app.trialscreen.org
app.trialscreen.org/trials/opioid-use-disorder-minds-mentors-program-mimp-r61-trial-nct04233671Minds and Mentors Program (MiMP)- R61
The goal of the proposed study is to determine the effectiveness of a mindfulness-based intervention that also utilizes peer mentors in addition ...
5.
centerwatch.com
centerwatch.com/clinical-trials/listings/NCT04233671/minds-and-mentors-program-mimp-r61Minds and Mentors Program (MiMP)- R61
The purpose of this study is as follows: Test the feasibility and acceptability of a twelve- week mindfulness based relapse prevention protocol ...
Mindfulness-based Relapse Prevention for Substance Use ...
This review aims to estimate the effects and safety of Mindfulness-based Relapse Prevention (MBRP) for SUDs. ... extracted all outcome data. Data Synthesis.
Research
Below are summaries of sample journal articles assessing the efficacy, effectiveness and mechanisms of mindfulness-based approaches to addictions treatment.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.